Drug intelligence / Profile preview

Zenith

Development stage: Preclinical
Lead developer: Zenith Epigenetics
Modality: Device-based Delivery → Drug Delivery Systems
Administration: Topical

Overview

Zenith is an amniotic membrane-based product designed to promote chronic wound healing. It is currently being evaluated in a multi-site observational study sponsored by Legacy Medical Consultants to assess its real-world effectiveness when used in addition to standard care for Diabetic Foot Ulcers, Venous Leg Ulcers, and Pressure Ulcers. The study aims to determine if Zenith improves healing outcomes, such as complete wound closure, time-to-healing, and early wound improvement, compared to standard care alone.

Brand names: Zenith

Beyond the preview

Go deeper on Zenith.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zenith.

Explore the full profile